Heidelberg Pharma Partner Telix Pharmaceuticals Provides Regulatory Update on Imaging Agent TLX250-CDx Read more
Zemcelpro Wins EC Approval as First Cell Therapy for Blood Cancer Patients Without Suitable Donors Read more